kabutan

COSMOS Pharma, First Half Ordinary Profit Increases by 26%

Fri Jan 10, 2025 3:30 pm JST Earnings

3349 COSMOS Pharmaceutical Corporation 【J-GAAP】

Earnings Report

COSMOS Pharmaceutical Corporation <3349> [TSE Prime] announced its financial results after the market closed on January 10th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending May 2025 (June to November) increased 25.5% from the same period last year, reaching 21.7 billion yen, exceeded the previous forecast of 17.4 billion yen.

The progress rate toward the full-year plan of 34.4 billion yen was 63.3%, also surpassing the five-year average of 49.6%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the December to May period (2H) is expected to decrease 25.5% from the same period last year to 12.6 billion yen.

In the most recent three-month period, from September to November (2Q), the consolidated ordinary profit grew 24.0% from the same period last year, reaching 9.48 billion yen. The operating profit margin improved from 2.9% in the same period last year to 3.6%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jun - Nov, 2022 404,016 15,385 16,900 11,299 142.7 51.1 Jan 13, 2023 J-GAAP
Jun - Nov, 2023 476,430 15,836 17,346 11,587 146.3 50.6 Jan 12, 2024 J-GAAP
Jun - Nov, 2024 505,936 20,344 21,777 14,428 182.1 63.3 Jan 10, 2025 J-GAAP
YoY +6.2% +28.5% +25.5% +24.5% +24.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun - Nov, 2024 Guidance 515,200 16,000 17,470 11,790 148.8 32.50 Jul 12, 2024 J-GAAP
Jun - Nov, 2024 Results 505,936 20,344 21,777 14,428 182.1 32.50 Jan 10, 2025 J-GAAP
Revision Rate -1.8% +27.2% +24.7% +22.4% +22.4%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec - May, 2023 488,559 15,665 16,953 12,867 162.4 30 Jul 12, 2024 J-GAAP
Dec - May, 2024 Guidance 531,064 11,256 12,623 10,072 127.1 32.50 Jan 10, 2025 J-GAAP
YoY +8.7% -28.1% -25.5% -21.7% -21.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2023 827,697 30,128 33,086 23,797 300.5 50 Jul 10, 2023 J-GAAP
May, 2024 964,989 31,501 34,299 24,454 308.6 60 Jul 12, 2024 J-GAAP
May, 2025 Guidance 1,037,000 31,600 34,400 24,500 309.1 65 Jul 12, 2024 J-GAAP
YoY +7.5% +0.3% +0.3% +0.2% +0.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Sep - Nov, 2023 234,777 6,846 7,647 5,079 64.1 2.9 Jan 12, 2024 J-GAAP
Dec - Feb, 2023 238,881 7,902 8,568 5,770 72.8 3.3 Apr 12, 2024 J-GAAP
Mar - May, 2024 249,678 7,763 8,385 7,097 89.6 3.1 Jul 12, 2024 J-GAAP
Jun - Aug, 2024 261,841 11,580 12,293 8,143 102.7 4.4 Oct 11, 2024 J-GAAP
Sep - Nov, 2024 244,095 8,764 9,484 6,285 79.3 3.6 Jan 10, 2025 J-GAAP
YoY +4.0% +28.0% +24.0% +23.7% +23.7%

Related Articles